Welcome to the e-CCO Library!

P514: Influence of the frequency of glucocorticosteroid therapy courses on the hormonal resistance in patients with ulcerative colitis.
Year: 2021
Source: ECCO'21 Virtual
Authors: Knyazev, O.(1,2,3);Tishaeva, I.(2);Kagramanova, A.(1);Shkurko, T.(3);Veselov, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P514: Optimising response to infliximab in the management of perianal Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: SHAH , R.(1);Anandbaskaran , S.(1);Hart , A.(1);Tozer , P.(1);
Created: Friday, 11 February 2022, 3:56 PM
P514: Serum levels of Klotho in inflammatory bowel disease: an exploratory study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hernandez-Camba, A.(1,2);Rodriguez-Jimenez, J.(1)*;Carrillo Palau, M.(3);Ramos Lopez, L.(3);Perez-Mendez , L.(4,5);Martin-Nuñez , E.(6);Alonso, I.(3);Vela, M.(1);Hernandez Alverez Builla, N.(3);Arranz, L.(1);Hernandez, A.(3);Ferraz Amaro, I.(7);Navarro‐Gonzalez, J.F.(6,8,9);
Created: Friday, 14 July 2023, 11:05 AM
P515 Comparability of upadacitinib pharmacokinetics in Japanese and non-Japanese subjects with ulcerative colitis with the extended-release formulation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Stodtmann1, A. Friedel1, W. Zhou2, M.E. MOHAMED3

Created: Thursday, 30 January 2020, 10:12 AM
P515: A 12-week tailored physical training program including dietary advice in children with Inflammatory Bowel Disease: a randomized crossover trial
Year: 2021
Source: ECCO'21 Virtual
Authors: Scheffers, L.(1);van den Berg, L.E.(1);Pijnenburg, M.W.(2);Utens, E.M.(3);Dieleman, G.C.(3);van der Ploeg , A.T.(4);Helbing, W.A.(5);Escher, J.C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P515: Costs associated with the management of refractory complex perianal fistulas in patients with Crohn's disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. D. Martín-Arranz*1, I. Pascual Migueláñez1, J. L. Marijuán1

Created: Friday, 22 February 2019, 9:41 AM
P515: Evaluation of treatment persistence of vedolizumab among Finnish inflammatory bowel disease patients in real-life clinical practice (FINVEDO)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ylisaukko-oja T.1,2,3, Eberl A.*4, Aaltonen J.1, Nuutinen H.5, Blomster T.6, Jussila A.7, Pajala M.8, Jokelainen J.2,3, Herrala S.3, Tamminen K.1, Sipponen T.4

Created: Wednesday, 20 February 2019, 10:36 AM
P515: Inflammatory bowel disease and malignancy – the outcome of patients with malignancy diagnosed before IBD diagnosis or IBD-targeted therapy
Year: 2022
Source: ECCO'22
Authors: Shani, U.(1);Klang, E.(2);Ungar, B.(3);Ben-Horin, S.(3);Kopylov, U.(3);
Created: Friday, 11 February 2022, 3:56 PM
P515: Infliximab desensitization in patients with Inflammatory Bowel Diseases: a safe therapeutic alternative
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hammoudi, N.(1)*;Hassid, D.(1);Bonnet, J.(1);Tran Minh, M.L.(1);Baudry, C.(1);Chedouba, L.(1);Vauthier, A.(1);Gornet, J.M.(1);Allez, M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P515: Manipulating the microbiome in paediatric acute severe colitis with a cocktail of antibiotics: A pilot randomised controlled trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Turner1*, H. Vlamakis2, D. Marcus1, M. Yassour2, J. Bishai2, B. Yerushalmi3, A. Griffiths4, M. Aloi5, L. Albenberg6, K.-L. Kolho7, G. Abutbul1, A. Assa8, R. Xavier2, A. Levine9

Created: Thursday, 21 February 2019, 9:14 AM
P516 Daily consumers of drip-filtered coffee have a decreased risk of developing late-onset Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Widbom1, J. Hultdin1, K. Ekblom2, P. Karling3, L.M. Nilsson4

Created: Thursday, 30 January 2020, 10:12 AM
P516: Adrenal suppression in inflammatory bowel disease patients treated with glucocorticoids: a systematic review
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Wood P.*1, Henderson P.1,2, Wilson D.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P516: Discrete choice experiment to examine patient preferences for surgical interventions in patients with Crohn’s perianal fistulas: results from a global burden of illness study
Year: 2022
Source: ECCO'22
Authors: Karki, C.(1);Athavale, A.(2);Hantsbarger, G.(3);Lee, K.(4);Milicevic, S.(5);Perovic, M.(6);Raven, L.(7);Sajak-Szczerba, M.(8);Abilash, V.(2);Tozer, P.(9);
Created: Friday, 11 February 2022, 3:56 PM
P516: Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trials
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Panés1*, B. Bressler2, J.-F. Colombel3, N. Lawendy4, E. Maller4, H. Zhang4, D.A. Woodworth4, G. Chan4, L. Salese4, C. Su4

Created: Thursday, 21 February 2019, 9:14 AM
P516: Humoral immune responses to SARS-CoV-2 vaccines in an ozanimod open-label extension study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Caldera, F.(1)*;Maddux, R.(2);Ungaro, R.(3);Kaur, A.(2);Brown, E.(2);Hu, S.(2);Sheffield, J.K.(2);Silva, D.(2);Harris, S.(2);Cree, B.A.C.(4);
Created: Friday, 14 July 2023, 11:05 AM
P516: Serological biomarkers of tissue remodeling are associated with endoscopic remission in Crohn’s disease patients treated with GED-0301 (mongersen)
Year: 2021
Source: ECCO'21 Virtual
Authors: Mortensen, J.(1);Feagan, B.(2);Bay-Jensen, A.C.(1);Karsdal, M.A.(1);Horan, G.(3);Harris, S.(4);Usikin, K.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P516: The use of first-line biologics in patients with ulcerative colitis in Norway from 2011 to 2016
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Anisdahl*1,2, S. Lirhus3, A. Medhus1, L. Buer1,2, H. O. Melberg3, B. Moum1,2, M. Lie Høivik1

Created: Friday, 22 February 2019, 9:41 AM
P517 A randomised, placebo-controlled pilot trial of faecal microbiota transplantation for paediatric Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Hill1,2, J. Popov1,3, E. Hartung1, M. Moshkovich1,4, M. Figueiredo1,4, N. Pai1,5, McMaster Paediatric FMT Research Program

Created: Thursday, 30 January 2020, 10:12 AM
P517: Activity assessment in ulcerative colitis: correlation analysis of endoscopic and histological scores
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, S. Orlandi1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

Created: Friday, 22 February 2019, 9:41 AM
P517: Features of cytomegalovirus infection in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Makarchuk P., Belousova E., Volchkova E., Kudriavtseva E.

Created: Wednesday, 20 February 2019, 10:36 AM